3Wiseman LR, Benfield P. Cefprozil, A review of its antibacterial activity, pharmacokinefic properties, and therapeutic potential. Drugs, 1993,45 (2) :295.
4Fung- Tome JC, Huezko Z, Stickle T, et al. Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides. Antimicrob Agents Chemother, 1995,39 ( 2 ) : 533.
4[1]WISE R.Comparative microbiological activity and pharmacokinetics of cefprozil[J].Eur J Clin Mcrobiol Infect Dis,1994,13(10):839-845.
5[2]SCHATZ BS,KARAVOKIROS KT,TAEUBEL MA,et al.Comparison of cefprozil,cefpodoxime proxetil,loracarbef,cefixime,and ceftibuten[J].Ann Pharmacother,1996,30(3):258-268.
6[3]DOERN GV,BRUEGGEMANN AB,HUYNH H,et al.Antimicrobial resistance with Streptococcus pneumoniae in the United States,1997-98[J].Emerg Infect Dis,1999,5(6):757-765.
7[4]McCARTY JM.Comparative efficacy and safety of cefprozil versus penicillin,cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis[J].Europ J Clin Mcrobiol Infect Dis,1994,13(10):846-850.
8[5]BALL P.Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections[J].Europ J Clin Mcrobiol Infect Dis,1994,13(10):851-856.
9[6]KAFETZIS DA.Multi-investigator evaluation of the efficacy and safety of cefprozil,amoxicillin-clavulanate,cefixime and cefaclor in the treatment of acute otitis media[J].Europ J Clin Mcrobiol Infect Dis,1994,13(10):857-865.
10[7]NOLEN T.Comparative studies of cefprozil in the management of skin and soft-tissue infections[J].Europ J Clin Mcrobiol Infect Dis,1994,13(10):866-871.
